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CD45 is increased in T cell-monocyte complexes compared to singlets (Figure 2B) , as both cells 1 0 2 express this marker. In RNAseq, TPM-transformed expression values identify the relative 1 0 3 concentration of different RNA species rather than providing an absolute quantification (such as 1 0 4 in flow cytometry). Thus, in scRNAseq, markers that are exclusively found in T cells or 1 0 5 exclusively found in monocytes are about half that expression level when evaluating complexes 1 0 6 compared to singlet T cells and monocytes (Figure 2C) . Whereas these parameters are not 1 0 7 sufficient to completely separate cell-cell complexes from single cells, they together represent 1 0 8 useful signatures at both protein and mRNA level that can be checked by investigators after the 1 0 9
data has been generated, and prompt for further cell-cell complexes analyses. 1 1 0
The by far preferred method to identify the presence of cell-cell complexes in a previously 1 1 1 uncharacterized cell population is to use imaging flow cytometry. The typical gating strategy is, 1 1 2 similarly to non-imaging flow cytometry (Figure 1A) : First identify cells, followed by dead cells 1 1 3 and doublets exclusion, to finally identify the double positive population (optimal (OPT) 1 1 4 imaging gating, Figure 3A ). However, imaging flow cytometry can identify doublets in a much 1 1 5 more dispositive fashion than a standard flow cytometer by generating metrics derived from an 1 1 6 actual picture of the event detected, which allows for the calculation of brightfield area and 1 1 7 aspect ratio parameters. Additionally, the accuracy of the doublet exclusion gating can be cross-1 1 8 checked by viewing an image gallery of all gated objects. When we applied the OPT imaging 1 1 9 gating strategy to the detection of CD3+CD14+ cells, it detected a much lower frequency of 1 2 0 double positive events compared to non-imaging flow cytometry (Figure 3C ). This signifies that 1 2 1 the doublet exclusion in the imaging flow cytometer is far more sensitive than what we can 1 2 2 expect from cell sorters relying on FSC and SSC based doublet exclusion, and results from the 1 2 3 two cannot be directly compared. The first gating step for cell selection in imaging flow 1 2 4 cytometry (SSC-A vs Brightfield Area) is sufficient to eliminate bigger aggregates (but not tight 1 2 5 doublets) in a similar fashion that A vs. W, W vs. H or A vs. H would perform in non-imaging 1 2 6 flow cytometry ( Figure 3B ). Using this cell sorting matching (CSM) gating strategy, we 1 2 7 identified frequencies of CD3+CD14+ cells similar to what cell sorters detected ( Figure 3C ). 1 2 8
Importantly, when exporting a gallery of events for both gating strategies, we identified that the 1 2 9
CSM gating strategy identified mostly T cell-monocyte complexes (Figure 3D ), whereas the 1 3 0
OPT imaging gating strategy identified predominantly dual expressers ( Figure 3E) . Thus, the 1 3 1 CSM gating strategy is more closely mimicking the population detected by cell sorters and non-1 3 2 imaging flow analyzers, and is a more reliable way to identify the possible presence of cell 1 3 3 complexes and their relative proportion over true dual expressers within an unknown dual-1 3 4 positive cell population. In the case of CD3+CD14+ cells, this experiment demonstrates that 1 3 5
whereas dual expressers do exist, the vast majority of dual positive events identified by flow 1 3 6 cytometry and cell sorting represent T cell-monocyte complexes. 1 3 7
To circumvent the hurdles associated with matching gating strategies between imaging flow 1 3 8 cytometry and cell sorting aforementioned, an alternative experiment is to directly sort the dual-1 3 9
expressing cell population onto a slide and analyze them using microscopy. In the case of 1 4 0 CD3+CD14+ cells, we observed that cells identified as dual expressers by FACS represented a 1 4 1 perfect stoichiometric mix of individual T cells and monocytes, but not dual expressers under the 1 4 2 microscope ( Figure 3F) . 1 4 3
Finally, we applied our expertise in T cell-monocyte complexes detection to other types of cell-1 4 4
cell complexes that can be present in PBMC. A recent paper published in Cell (5) describes the 1 4 5 discovery of a novel immune cell type expressing both T cell and B cell receptors in the 1 4 6 peripheral blood of type I diabetes patients. These findings reminded us of our initial assumption 1 4 7 that we had identified a novel cell population with both T cell and monocyte lineage properties. Contrastingly, the OPT imaging gating strategy identified a much lower frequency of double 1 6 0 positive events (Figure 4D) , all of which were dual expressers ( Figure 4F) . Thus, in our hands, While the imaging data presented in the paper is limited to a single cell, the staining for both 1 8 6 TCR and IgD is uniform on the cell surface, and it represents a convincing dual expresser. Thus, 1 8 7 our concern is not that the DE cell presented in the Ahmed study is not real, but rather that large 1 8 8 parts of their subsequent experiments were solely based on non-imaging flow cytometry and the 1 8 9 assumption that DE cells are always singlets. Given the limitations of non-imaging flow 1 9 0 cytometry to distinguish cell-cell complexes from singlet cells aforementioned, this is potentially 1 9 1 problematic. Their gating strategy for imaging flow cytometry was described as 'focused cells 1 9 2 were selected on the basis of gradient RMS and an aspect ratio that was consistent with single 1 9 3 cell events and devoid of debris or multi-cellular events (doublets)' (5). Thus, it appears that the 1 9 4 optimal imaging gating strategy was used here, which we have shown does not reflect adequately 1 9 5 what is being detected by cell sorters. In this study, we have examined PBMCs from healthy 1 9 6 donors and found that in non-perturbed settings, DE cells do have a flow cytometry signature of 1 9 7
T cell-B cell complexes, with few dual expressing cells. The presence of dual expressers in the 1 9 8 DE cell population could thus be unique to the three type I diabetes patients included in the 1 9 9
Ahmed et al. study. However, the fact that sorted DE cells in the Ahmed study have a scRNA-2 0 0 seq signature of complexes suggest that our conclusion might also hold for the Ahmed et al. 2 0 1 study as well. Besides, dual expressers identified by imaging flow cytometry might not 2 0 2 necessarily represent a novel immune cell type, but could also be conventional T cells or B cells 2 0 3 that have acquired the other lineage markers at the protein level following cell-cell interaction by 2 0 4 trogocytosis, a common phenomenon occurring between immune cells (7, 8). should be performed such as direct microscopy analysis on sorted cells. Imaging cell sorters are 2 1 1 being developed but have not reached yet the speed and sensitivity required for the detection of 2 1 2 rare events, including cell-cell complexes. Until such technology is made commercially 2 1 3 available, these recommendations will be crucial to ensure reliable interpretation of single cell 2 1 4 datasets derived from flow cytometry, especially those reporting on the discovery of novel 2 1 5 0 monocytes and CD3+CD14+ cells were identified based on the gating strategy presented in 2 7 1 Figure 1A . Sorts were performed on a BD Aria III cell sorter directly into a 96-well PCR plate 2 7 2 containing 4 μ l cell lysis buffer for single cell sorts, or in Eppendorf tubes containing staining 2 7 3 buffer for bulk sorts. Single cell RNA sequencing was performed using Smart-seq2 as previously described (9). RNA 2 7 6 loss was minimized by performing on-plate RNA capture, reverse-transcription and whole 2 7 7 transcriptome pre-amplification (24 cycles) that results in ~1-30 ng of cDNA as previously 2 7 8 described (9). 0.3 to 0.5 ng of pre-amplified cDNA was used to generate barcoded Illumina 2 7 9
sequencing libraries (Nextera XT library preparation kit, Illumina) in an 8µL reaction volume. 2 8 0
Multiple quality-control steps were included to ensure consistency during the procedure for all 2 8 1 samples. Samples that failed at quality-control steps as described in (9, 10), were eliminated 2 8 2 from downstream procedures and analysis. Libraries were pooled and sequenced on the 2 8 3
HiSeq2500 Illumina platform to obtain more than 2 million 50-bp single end reads per cell. 2 8 4
Single cell RNA sequencing data were mapped against the human hg19 reference genome using 2 8 5
TopHat (v1.4.1., --library-type fr-secondstrand -C) and Gencode version 19 (GRCh37.p13) as 2 8 6 gene model reference for alignment. Sequencing read coverage per gene was counted using 
